首页|基于SEER数据库的恶性腹膜间皮瘤患者生存分析

基于SEER数据库的恶性腹膜间皮瘤患者生存分析

扫码查看
目的 基于监测、流行病学和最终结果(SEER)数据库分析恶性腹膜间皮瘤(MPM)患者生存结局及预后影响因素.方法 回顾性分析2004-2017年SEER数据库中被确诊为MPM患者人口学特征、临床病理资料及肿瘤特异性生存率(CSS),并对其预后影响因素进行单因素及多因素Cox回归分析.结果 516例MPM患者1、3、5年CSS分别为55.7%、32.9%、27.6%.95例MPM患者的单因素Cox回归分析显示,≥65岁、男性、纤维肉瘤型、中分化、低分化、未分化、肿瘤远处转移、手术是影响MPM患者生存率的危险因素(P<0.05).不同年龄、性别、病理组织类型、病理分级、SEEER综合分期及是否手术的MPM患者累积生存率比较,差异有统计学意义(P<0.05).多因素Cox回归分析显示,纤维肉瘤型(P=0.036)、中等分化(P=0.012)、低分化(P<0.001)、未分化(P<0.001)、肿瘤远处转移(P=0.005)、化疗(P=0.010)是MPM患者预后的独立危险因素.结论 MPM患者预后与肿瘤病理类型、病理分级、SEER综合分期及是否化疗有关.
Survival analysis of patients with malignant peritoneal mesothelioma based on SEER database
Objective To analyze the survival outcomes and prognostic factors of patients with malig-nant peritoneal mesothelioma(MPM)based on the Surveillance,Epidemiology,and End Results(SEER)data-base.Methods A retrospective analysis of demographic characteristics,clinicopathological data,and cancer-specific survival(CSS)rates of the patients diagnosed with MPM from 2004 to 2017 in the SEER database was conduc-ted.Prognostic factors were assessed using univariate and multivariate Cox regression analyses.Results Among 516 MPM patients,the 1-,3-,and 5-year CSS rates were 55.7%,32.9%,and 27.6%,respectively.Univariate Cox regression analysis of 95 MPM patients indicated that age ≥65 years,male sex,sarcomatoid subtype,moderate differentiation,poor differentiation,undifferentiated tumors,distant metastasis,and absence of surgery were significant risk factors affecting patient survival(P<0.05).Comparison of cumulative survival rates among MPM patients stratified by different ages,sexes,histological subtypes,pathological grades,SEER stage,and surgical status showed statistically significant differences(P<0.05).Multivariate Cox regression analysis re-vealed that sarcomatoid subtype(P=0.036),moderate differentiation(P=0.012),poor differentiation(P<0.001),undifferentiated tumors(P<0.001),distant metastasis(P=0.005),and chemotherapy(P=0.010)were independent adverse prognostic factors for the MPM patients.Conclusion Prognosis of MPM patients is associated with tumor histological subtype,pathological grade,SEER stage,and chemotherapy status.

Malignant peritoneal mesotheliomaDatabaseSurvival analysisPrognosis

吴津文、曾琪

展开 >

赣南医科大学第一附属医院/赣南医科大学第一临床医学院超声医学科,江西赣州 341000

恶性腹膜间皮瘤 数据库 生存分析 预后

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(15)
  • 2